Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
Proteomic technologies are capable of identifying thousands of proteins in biological samples, but biomarker applications are lagging. Here the authors use Multiple Reaction Monitoring Mass Spectrometry to delineate peptide signatures that accurately distinguish between defined prostate cancer patie...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms11906 |